In the context of metabolic disease, thymosin-4 is of interest due to the growing recognition that chronic low-grade inflammation and impaired tissue repair contribute to insulin resistance, cardiovascular disease, and aging
Gradually increasing fiber intake in consultation with a dietitian allows for proper monitoring and adjustment of the meal plan to mitigate potential adverse effects
These usually fade quickly
GLP-1 agonists within the gut assist with weight loss by decreasing appetite and promoting satiety.3 They slow gastric emptying, promote satiety, and decrease postprandial glucose levels
While these trials confirm the short-term effectiveness of the drugs, they highlight the need for caution regarding long-term weight maintenance
Key Findings 93.4% of patients would get bariatric surgery again 51.4% of patients would consider using GLP-1 drugs again 57.1% of GLP-1 patients reported losing at least 20 pounds 98.1% of bariatric surgery patients reported losing at least 20 pounds Median weight loss for bariatric surgery patients was 100 pounds, as opposed to 20 for GLP-1s Average weight loss for bariatric surgery was reported to be 101.2, as opposed to 24.9 for GLP-1 users 93.4% of Patients Would Get Bariatric Surgery Again Out of all patients surveyed, 93.4% said they would get bariatric surgery again